doi: 10.3390/nu12010153 28 BhattGCJainSDasRR
Medical Evaluation Your provider may recommend lab testing to evaluate metabolic health, hormone balance, kidney and liver function, and inflammation markers
The aim of our analysis is to determine the efficacy of relative pharmacologic treatment options for clinical decision making in this metabolically complex condition
[6] Pharmacodynamic synergy with other carbonic-anhydrase inhibitors (acetazolamide, zonisamide) amplifies the risk of metabolic acidosis and nephrolithiasis, while combined use with valproate has been repeatedly implicated in hyperammonemic encephalopathy even at therapeutic serum valproate levels
Available from: Chen S, Yan S, Aiheti N, Kuribanjiang K, Yao X, Wang Q, et al